Antares Pharma, Inc. NDCs and Package Codes
This page lists NDC package records associated with labeler code 54436 (Antares Pharma, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
29
Package NDCs
10
Products
10
Active listings
0
Discontinued
2
Ingredients
0
Therapeutic classes
2
Dosage forms
6
With NADAC pricing
Portfolio
Top ingredients
By dosage form
Browse records — 10 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| Otrexup methotrexate 10 mg/.4mL INJECTION, SOLUTION | 54436-0010-01 | — | On market | View → |
| Otrexup methotrexate 20 mg/.4mL INJECTION, SOLUTION | 54436-0020-01 | — | On market | View → |
| Otrexup methotrexate 15 mg/.4mL INJECTION, SOLUTION | 54436-0015-01 | — | On market | View → |
| Otrexup methotrexate 12.5 mg/.4mL INJECTION, SOLUTION | 54436-0012-01 | — | On market | View → |
| Otrexup methotrexate 22.5 mg/.4mL INJECTION, SOLUTION | 54436-0022-01 | — | On market | View → |
| Otrexup methotrexate 25 mg/.4mL INJECTION, SOLUTION | 54436-0025-01 | — | On market | View → |
| Otrexup methotrexate 17.5 mg/.4mL INJECTION, SOLUTION | 54436-0017-01 | — | On market | View → |
| XYOSTED testosterone enanthate 75 mg/.5mL INJECTION | 54436-0275-01 | — | On market | View → |
| XYOSTED testosterone enanthate 100 mg/.5mL INJECTION | 54436-0200-01 | — | On market | View → |
| XYOSTED testosterone enanthate 50 mg/.5mL INJECTION | 54436-0250-01 | — | On market | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.